Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma

Apoptosis

Volumn 19, Issue 4, 2014, Pages 748-758

  Wang, Yu Fan ^a   Zhang, Wei ^a   He, Ke Fei ^a   Liu, Bing ^a   Zhang, Lu ^a   Zhang, Wen Feng ^a   Kulkarni, Ashok B ^b   Zhao, Yi Fang ^a   Sun, Zhi Jun ^a  

^a Wuhan University   (China)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Adenoid cystic carcinoma; Apoptosis; Autophagy; Survivin; YM155

Indexed keywords

CHLOROQUINE; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN S6; SEPANTRONIUM BROMIDE; SURVIVIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EB; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BIRC5 PROTEIN, HUMAN; IMIDAZOLE DERIVATIVE; INHIBITOR OF APOPTOSIS PROTEIN; NAPHTHOQUINONE;

ADENOID CYSTIC CARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL NUCLEUS; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; TREATMENT OUTCOME; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CARCINOMA, ADENOID CYSTIC; DRUG EFFECTS; METABOLISM; MOUTH NEOPLASMS; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; SALIVARY GLAND; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CARCINOMA, ADENOID CYSTIC; CELL LINE, TUMOR; FEMALE; HETEROGRAFTS; HUMANS; IMIDAZOLES; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOUTH NEOPLASMS; NAPHTHOQUINONES; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; SALIVARY GLANDS; SIGNAL TRANSDUCTION;

EID: 84896394478     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-013-0960-1     Document Type: Article

References (39)

1. Vekony H, Ylstra B, Wilting SM et al (2007) DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma. Clin Cancer Res 13:3133-3139
2. Laurie SA, Ho AL, Fury MG, Sherman E, Pfister DG (2011) Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncol 12:815-824
3. Ramalingam SS, Kummar S, Sarantopoulos J et al (2010) Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study. J Clin Oncol 28:4507-4512
4. Brown JM, Attardi LD (2005) The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5:231-237
5. Schimmer AD (2004) Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 64:7183-7190
6. Khan S, Jutzy JM, Aspe JR, McGregor DW, Neidigh JW, Wall NR (2011) Survivin is released from cancer cells via exosomes. Apoptosis 16:1-12
7. Schlette EJ, Medeiros LJ, Goy A, Lai R, Rassidakis GZ (2004) Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol 22:1682-1688
8. Nakahara T, Kita A, Yamanaka K et al (2007) YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res 67:8014-8021
9. Satoh T, Okamoto I, Miyazaki M et al (2009) Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors. Clin Cancer Res 15:3872-3880
10. Giaccone G, Zatloukal P, Roubec J et al (2009) Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer. J Clin Oncol 27:4481-4486
11. Wang Q, Chen Z, Diao X, Huang S (2011) Induction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cells. Cancer Lett 302:29-36
12. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132:27-42
13. Giampietri C, Petrungaro S, Padula F et al (2012) Autophagy modulators sensitize prostate epithelial cancer cell lines to TNF-alpha-dependent apoptosis. Apoptosis 17:1210-1222
14. Fiorini C, Menegazzi M, Padroni C et al (2013) Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. Apoptosis 18:337-346
15. Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451:1069-1075
16. Pattingre S, Tassa A, Qu X et al (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122:927-939
17. Kihara A, Kabeya Y, Ohsumi Y, Yoshimori T (2001) Beclin- phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep 2:330-335
18. Davis IJ, Hsi BL, Arroyo JD et al (2003) Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci USA 100:6051-6056
19. Settembre C, Di Malta C, Polito VA et al (2011) TFEB links autophagy to lysosomal biogenesis. Science 332:1429-1433
20. Pena-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC et al (2011) Regulation of TFEB and V-ATPases by mTORC1. EMBO J 30:3242-3258
21. David R (2011) Autophagy: TFEB perfects multitasking. Nat Rev Mol Cell Biol 12:404
22. Roczniak-Ferguson A, Petit CS, Froehlich F et al (2012) The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci signal 5:ra42
23. Sun ZJ, Chen G, Hu X et al (2010) Activation of PI3 K/Akt/IKK-alpha/NF- kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin. Apoptosis 15:850-863
24. Sun ZJ, Chen G, Zhang W et al (2010) Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase. J Pharmacol Exp Ther 334:500-512
25. Chen G, Hu X, Zhang W et al (2012) Mammalian target of rapamycin regulates isoliquiritigenin-induced autophagic and apoptotic cell death in adenoid cystic carcinoma cells. Apoptosis 17:90-101
26. Sun ZJ, Chen G, Zhang W et al (2011) Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-kappaB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IkappaB kinase complex signaling axis in adenoid cystic carcinoma. Mol Pharmacol 79:106-118
27. Liu H, Chen G, Zhang W et al (2013) Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential. J Cancer Res Clin Oncol 139:287-295
28. Nakahara T, Kita A, Yamanaka K et al (2011) Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models. Cancer Sci 102:614-621
29. de Bruin EC, Medema JP (2008) Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev 34:737-749
30. Fimia GM, Piacentini M (2010) Regulation of autophagy in mammals and its interplay with apoptosis. Cell Mol Life Sci 67:1581-1588
31. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8:741-752
32. Sharma N, Thomas S, Golden EB et al (2012) Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer Lett 326:143-154
33. Frierson HF Jr, El-Naggar AK, Welsh JB et al (2002) Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 161:1315-1323
34. Niu TK, Cheng Y, Ren X, Yang JM (2010) Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis. FEBS Lett 584:3519-3524
35. Roca H, Varsos Z, Pienta KJ (2008) CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. J Biol Chem 283:25057-25073
36. Na YS, Yang SJ, Kim SM et al (2012) YM155 induces EGFR suppression in pancreatic cancer cells. PLoS One 7:e38625
37. Zaytseva YY, Valentino JD, Gulhati P, Evers BM (2012) mTOR inhibitors in cancer therapy. Cancer Lett 319:1-7
38. Martina JA, Chen Y, Gucek M, Puertollano R (2012) MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8:903-914
39. Pena-Llopis S, Brugarolas J (2011) TFEB, a novel mTORC1 effector implicated in lysosome biogenesis, endocytosis and autophagy. Cell Cycle 10:3987-3988